Achilles Therapeutics (ACHL) Announces Research Collaboration with Arcturus Therapeutics (ARCT) to Explore Second-Generation Personalized mRNA Cancer Vaccines May 22, 2024 07:02AM
Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation Personalized mRNA Cancer Vaccines May 22, 2024 07:00AM
Achilles Therapeutics Selects Netrality’s 401 North Broad for United States Headquarters Mar 1, 2022 09:00AM
Annual Changes to the Nasdaq Biotechnology Index Dec 10, 2021 08:00PM